AllianceBernstein’s Immunomedics Inc IMMU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-170,129
| Closed | -$14.5M | – | 3251 |
|
|
2020
Q3 | $14.5M | Buy |
170,129
+67,331
| +65% | +$3.4M | 0.01% | 906 |
|
|
2020
Q2 | $3.64M | Sell |
102,798
-169,100
| -62% | -$4.94M | ﹤0.01% | 1503 |
|
|
2020
Q1 | $3.67M | Buy |
271,898
+15,000
| +6% | +$252K | ﹤0.01% | 1329 |
|
|
2019
Q4 | $5.44M | Hold |
256,898
| – | – | ﹤0.01% | 1391 |
|
|
2019
Q3 | $3.41M | Buy |
256,898
+7,300
| +3% | +$107K | ﹤0.01% | 1618 |
|
|
2019
Q2 | $3.46M | Buy |
249,598
+46,100
| +23% | +$694K | ﹤0.01% | 1648 |
|
|
2019
Q1 | $3.91M | Hold |
203,498
| – | – | ﹤0.01% | 1510 |
|
|
2018
Q4 | $2.9M | Buy |
203,498
+8,900
| +5% | +$177K | ﹤0.01% | 1621 |
|
|
2018
Q3 | $4.05M | Sell |
194,598
-150,000
| -44% | -$3.55M | ﹤0.01% | 1423 |
|
|
2018
Q2 | $8.16M | Buy |
344,598
+41,700
| +14% | +$838K | 0.01% | 1043 |
|
|
2018
Q1 | $4.42M | Buy |
302,898
+153,200
| +102% | +$2.5M | ﹤0.01% | 1285 |
|
|
2017
Q4 | $2.42M | Sell |
149,698
-6,100
| -4% | -$72K | ﹤0.01% | 1728 |
|
|
2017
Q3 | $2.18M | Sell |
155,798
-22,400
| -13% | -$223K | ﹤0.01% | 1793 |
|
|
2017
Q2 | $1.57M | Buy |
178,198
+4,200
| +2% | +$29.5K | ﹤0.01% | 2010 |
|
|
2017
Q1 | $1.13M | Sell |
173,998
-11,500
| -6% | -$58.3K | ﹤0.01% | 2182 |
|
|
2016
Q4 | $681K | Hold |
185,498
| – | – | ﹤0.01% | 2441 |
|
|
2016
Q3 | $603K | Hold |
185,498
| – | – | ﹤0.01% | 2460 |
|
|
2016
Q2 | $430K | Buy |
185,498
+72,200
| +64% | +$241K | ﹤0.01% | 2566 |
|
|
2016
Q1 | $283K | Hold |
113,298
| – | – | ﹤0.01% | 2615 |
|
|
2015
Q4 | $348K | Hold |
113,298
| – | – | ﹤0.01% | 2577 |
|
|
2015
Q3 | $195K | Hold |
113,298
| – | – | ﹤0.01% | 2786 |
|
|
2015
Q2 | $460K | Hold |
113,298
| – | – | ﹤0.01% | 2614 |
|
|
2015
Q1 | $434K | Hold |
113,298
| – | – | ﹤0.01% | 2547 |
|
|
2014
Q4 | $544K | Sell |
113,298
-6,500
| -5% | -$25.7K | ﹤0.01% | 2492 |
|
|
2014
Q3 | $446K | Sell |
119,798
-6,200
| -5% | -$21K | ﹤0.01% | 2540 |
|
|
2014
Q2 | $460K | Sell |
125,998
-3,600
| -3% | -$13.2K | ﹤0.01% | 2539 |
|
|
2014
Q1 | $546K | Buy |
129,598
+29,500
| +29% | +$146K | ﹤0.01% | 2403 |
|
|
2013
Q4 | $460K | Buy |
100,098
+500
| +0.5% | +$2.23K | ﹤0.01% | 2472 |
|
|
2013
Q3 | $617K | Sell |
99,598
-583
| -0.6% | -$3.36K | ﹤0.01% | 2371 |
|
|
2013
Q2 | $545K | Buy |
+100,181
| New | +$329K | ﹤0.01% | 2436 |
|
AllianceBernstein's IMMU Position: Q4 2020 in Review
AllianceBernstein sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 170,129 shares — an estimated $14.5M sold.
AllianceBernstein first reported a position in IMMU in Q2 2013 and held it in 30 quarters. The position peaked at $14.5M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.
- AllianceBernstein reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
- AllianceBernstein sold 170,129 Immunomedics Inc shares in Q4 2020, an estimated $14.5M.
- AllianceBernstein first reported a position in Immunomedics Inc in Q2 2013 and held it in 30 quarters.
- AllianceBernstein's Immunomedics Inc position peaked at $14.5M in Q3 2020.
- 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.
Based on AllianceBernstein's 13F filing for Q4 2020, filed 8 Feb 2021.